Cologne Cohort Study of Patients with Neutropenia After Chemotherapy for Blood Cancers and Other Malignancies

What this Trial Is About

The Cologne Cohort of Neutropenic Patients CoCoNut is a non-interventional observational study focused on examining risk factors, treatments, and outcomes in patients who have weakened immune systems due to neutropenia after chemotherapy for various cancers. The study collects detailed data to better understand these patients health and infection risks. Participants in this study include immunosuppressed patients who have developed neutropenia following chemotherapy. The study observes the use and effectiveness of antiinfective drug therapies among these high-risk patients, aiming to analyze how these treatments work in real-world settings without altering their usual medical care. During the study, researchers collect comprehensive patient data over time to evaluate long-term survival outcomes, particularly looking at hematology and oncology patients two years after their last follow-up. The study involves ongoing monitoring of patient health, interventions, and any opportunistic infections, with participation lasting as long as patients continue to be followed in the cohort.

Cologne Cohort of Neutropenic Patients (CoCoNut)